{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:51:45Z","timestamp":1788871905866,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier","isbn-type":[{"value":"9780323994316","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["MLP2030"],"award-info":[{"award-number":["MLP2030"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.pmbts.2022.06.004","type":"book-chapter","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T20:50:57Z","timestamp":1658523057000},"page":"99-117","source":"Crossref","is-referenced-by-count":4,"title":["Targeting G protein coupled receptors for alleviating neuropathic pain"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2022.06.004_bb0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","article-title":"Beta-arrestins and cell signaling","volume":"69","author":"DeWire","year":"2007","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.004_bb0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01200143","article-title":"Nobel lecture. G proteins and regulation of adenylyl cyclase","volume":"15","author":"Gilman","year":"1995","journal-title":"Biosci Rep"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.004_bb0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.004_bb0025","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/j.pain.0000000000000454","article-title":"Pain and the global burden of disease","volume":"157","author":"Rice","year":"2016","journal-title":"Pain"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.004_bb0030","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1474-4422(18)30071-1","article-title":"Diagnosis and assessment of neuropathic pain through questionnaires","volume":"17","author":"Attal","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.004_bb0035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00702-020-02145-7","article-title":"Challenges of neuropathic pain: focus on diabetic neuropathy","volume":"127","author":"Rosenberger","year":"2020","journal-title":"J Neural Transm (Vienna)"},{"issue":"8","key":"10.1016\/bs.pmbts.2022.06.004_bb0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrd.2017.87","article-title":"Breaking barriers to novel analgesic drug development","volume":"16","author":"Yekkirala","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"3 Suppl","key":"10.1016\/bs.pmbts.2022.06.004_bb0045","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.004_bb0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.117.014399","article-title":"Etiology and pharmacology of neuropathic pain","volume":"70","author":"Alles","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.004_bb0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"issue":"18","key":"10.1016\/bs.pmbts.2022.06.004_bb0060","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1021\/acs.biochem.0c00644","article-title":"Advances in the treatment of chronic pain by targeting GPCRs","volume":"60","author":"Che","year":"2021","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/bs.pmbts.2022.06.004_bb0065","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: A generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J Pain"},{"issue":"43","key":"10.1016\/bs.pmbts.2022.06.004_bb0070","doi-asserted-by":"crossref","first-page":"11614","DOI":"10.1523\/JNEUROSCI.3769-07.2007","article-title":"Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria","volume":"27","author":"Bruchas","year":"2007","journal-title":"J Neurosci"},{"issue":"22","key":"10.1016\/bs.pmbts.2022.06.004_bb0075","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1523\/JNEUROSCI.0176-07.2007","article-title":"Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain","volume":"27","author":"Guo","year":"2007","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.004_bb0080","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neulet.2006.08.034","article-title":"Expression of IL-1beta in supraspinal brain regions in rats with neuropathic pain","volume":"407","author":"Apkarian","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.expneurol.2014.09.019","article-title":"Activation of spinal chemokine receptor CXCR3 mediates bone cancer pain through an Akt-ERK crosstalk pathway in rats","volume":"263","author":"Guan","year":"2015","journal-title":"Exp Neurol"},{"issue":"5610","key":"10.1016\/bs.pmbts.2022.06.004_bb0090","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.1080659","article-title":"Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia","volume":"299","author":"Ikeda","year":"2003","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-540-33823-9_2","article-title":"Opioids","volume":"177","author":"Zollner","year":"2007","journal-title":"Handb Exp Pharmacol"},{"issue":"4119","key":"10.1016\/bs.pmbts.2022.06.004_bb0100","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.182.4119.1359","article-title":"Opiate agonists and antagonists discriminated by receptor binding in brain","volume":"182","author":"Pert","year":"1973","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00000441-197309000-00001","article-title":"In search of the opiate receptor","volume":"266","author":"Simon","year":"1973","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/mol.106.026740","article-title":"Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain","volume":"71","author":"Endres-Becker","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"12","key":"10.1016\/bs.pmbts.2022.06.004_bb0115","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/nn1804","article-title":"Dynorphin a activates bradykinin receptors to maintain neuropathic pain","volume":"9","author":"Lai","year":"2006","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0143-4179(98)90022-1","article-title":"Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1-17 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampus","volume":"32","author":"Caudle","year":"1998","journal-title":"Neuropeptides"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.004_bb0125","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jpain.2008.12.002","article-title":"Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients","volume":"10","author":"Mercadante","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fphar.2019.00407","article-title":"A review of the therapeutic potential of recently developed G protein-biased kappa agonists","volume":"10","author":"Mores","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/164_2021_434","article-title":"Kappa opioid signaling at the crossroads of chronic pain and opioid addiction","volume":"271","author":"Cahill","year":"2022","journal-title":"Handb Exp Pharmacol"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.004_bb0140","first-page":"255","article-title":"Dopamine D1 receptor agonists as antiparkinson drugs","volume":"19","author":"Mailman","year":"1998","journal-title":"Trends Pharmacol Sci"},{"issue":"456","key":"10.1016\/bs.pmbts.2022.06.004_bb0145","doi-asserted-by":"crossref","first-page":"ra117","DOI":"10.1126\/scisignal.aai8441","article-title":"Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria","volume":"9","author":"Brust","year":"2016","journal-title":"Sci Signal"},{"issue":"15","key":"10.1016\/bs.pmbts.2022.06.004_bb0150","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/bph.13854","article-title":"Selective kappa receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice","volume":"174","author":"Spetea","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.004_bb0155","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/acsmedchemlett.7b00224","article-title":"Seeking (and finding) biased ligands of the kappa opioid receptor","volume":"8","author":"Bohn","year":"2017","journal-title":"ACS Med Chem Lett"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0160","doi-asserted-by":"crossref","first-page":"E587","DOI":"10.1208\/aapsj070360","article-title":"Mu opioid receptor regulation and opiate responsiveness","volume":"7","author":"Raehal","year":"2005","journal-title":"AAPS J"},{"issue":"7619","key":"10.1016\/bs.pmbts.2022.06.004_bb0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/bs.pmbts.2022.06.004_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079239","article-title":"Effect of chronic pain on fentanyl self-administration in mice","volume":"8","author":"Wade","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/bs.pmbts.2022.06.004_bb0175","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.289.18.2370","article-title":"Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities","volume":"289","author":"Rosenblum","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","article-title":"Opioid receptors: Distinct roles in mood disorders","volume":"36","author":"Lutz","year":"2012","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.004_bb0185","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neuron.2015.08.019","article-title":"Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward","volume":"87","author":"Al-Hasani","year":"2012","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.004_bb0190","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiol Rev"},{"issue":"4","key":"10.1016\/bs.pmbts.2022.06.004_bb0195","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2014.05.025","article-title":"Upregulation of tumor necrosis factor-alpha in nucleus accumbens attenuates morphine-induced rewarding in a neuropathic pain model","volume":"449","author":"Wu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"10.1016\/bs.pmbts.2022.06.004_bb0200","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1523\/JNEUROSCI.0274-19.2019","article-title":"Kappa opioid receptors drive a tonic aversive component of chronic pain","volume":"39","author":"Liu","year":"2019","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0205","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain","volume":"43","author":"Donvito","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.004_bb0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.004_bb0215","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3565(24)37642-6","article-title":"Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A","volume":"286","author":"Vivian","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.004_bb0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-008-1157-0","article-title":"Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: Discrimination and antinociception","volume":"199","author":"Li","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0225","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2016.05.018","article-title":"Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl","volume":"784","author":"Maguire","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"2\u20133","key":"10.1016\/bs.pmbts.2022.06.004_bb0230","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2010.09.004","article-title":"The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects","volume":"60","author":"Kinsey","year":"2011","journal-title":"Neuropharmacology"},{"issue":"13","key":"10.1016\/bs.pmbts.2022.06.004_bb0235","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/npp.2015.148","article-title":"A cannabinoid CB1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects","volume":"40","author":"Ignatowska-Jankowska","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0240","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1213\/ane.0b013e31818c7cbd","article-title":"Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase","volume":"108","author":"Karbarz","year":"2009","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0245","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pain.2004.01.022","article-title":"Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia","volume":"109","author":"Lichtman","year":"2004","journal-title":"Pain"},{"issue":"1\u20133","key":"10.1016\/bs.pmbts.2022.06.004_bb0250","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2013.01.077","article-title":"Involvement of the opioid and cannabinoid systems in pain control: new insights from knockout studies","volume":"716","author":"Nadal","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0255","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainresbull.2015.03.005","article-title":"CB1 receptors modulate affective behaviour induced by neuropathic pain","volume":"114","author":"Racz","year":"2015","journal-title":"Brain Res Bull"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.004_bb0260","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nn1916","article-title":"Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors","volume":"10","author":"Agarwal","year":"2007","journal-title":"Nat Neurosci"},{"issue":"11","key":"10.1016\/bs.pmbts.2022.06.004_bb0265","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nrn2255","article-title":"Chemokines: a new class of neuromodulator?","volume":"8","author":"Rostene","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2022.06.004_bb0270","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","article-title":"Glia and pain: is chronic pain a gliopathy?","volume":"154","author":"Ji","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0275","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuron.2009.09.033","article-title":"Current challenges in glia-pain biology","volume":"64","author":"McMahon","year":"2009","journal-title":"Neuron"},{"issue":"15","key":"10.1016\/bs.pmbts.2022.06.004_bb0280","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1523\/JNEUROSCI.5169-09.2010","article-title":"Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury","volume":"30","author":"Calvo","year":"2010","journal-title":"J Neurosci"},{"issue":"14","key":"10.1016\/bs.pmbts.2022.06.004_bb0285","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1523\/JNEUROSCI.21-14-05027.2001","article-title":"Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons","volume":"21","author":"Oh","year":"2001","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0290","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(01)00404-3","article-title":"A comparison of chronic pain behavior following local application of tumor necrosis factor alpha to the normal and mechanically compressed lumbar ganglia in the rat","volume":"95","author":"Homma","year":"2002","journal-title":"Pain"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0295","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1471-4159.2006.03746.x","article-title":"Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury","volume":"97","author":"Zhang","year":"2006","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3959(01)00339-6","article-title":"Protein kinase a modulates spontaneous activity in chronically compressed dorsal root ganglion neurons in the rat","volume":"94","author":"Hu","year":"2001","journal-title":"Pain"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.004_bb0305","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"10.1016\/bs.pmbts.2022.06.004_bb0310","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1523\/JNEUROSCI.3623-08.2009","article-title":"JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain","volume":"29","author":"Gao","year":"2009","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0315","first-page":"685","article-title":"Promoted interaction of C\/EBPalpha with demethylated Cxcr3 gene promoter contributes to neuropathic pain in mice","volume":"37","author":"Jiang","year":"2017","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/bs.pmbts.2022.06.004_bb0320","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41386-018-0115-8","article-title":"Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell","volume":"43","author":"Wu","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0325","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2014a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0330","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918777401","article-title":"Spinal CXCL9 and CXCL11 are not involved in neuropathic pain despite an upregulation in the spinal cord following spinal nerve injury","volume":"14","author":"Wu","year":"2018","journal-title":"Mol Pain"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12264-020-00608-1","article-title":"CXCL10\/CXCR3 signaling in the DRG exacerbates neuropathic pain in mice","volume":"37","author":"Kong","year":"2020","journal-title":"Neurosci Bull"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058369","article-title":"Bayesian inference for generalized linear mixed model based on the multivariate t distribution in population pharmacokinetic study","volume":"8","author":"Yan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2015.10.031","article-title":"Adenosine receptor targets for pain","volume":"338","author":"Sawynok","year":"2015","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update","volume":"63","author":"Fredholm","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0355","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/bs.pmbts.2022.06.004_bb0360","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1213\/ane.0b013e318173251f","article-title":"Expression of adenosine A 2A receptors in the rat lumbar spinal cord and implications in the modulation of N-methyl-d-aspartate receptor currents","volume":"106","author":"Guntz","year":"2008","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0365","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1523\/JNEUROSCI.4591-03.2004","article-title":"Input-specific modulation of neurotransmitter release in the lateral horn of the spinal cord via adenosine receptors","volume":"24","author":"Brooke","year":"2004","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/bs.pmbts.2022.06.004_bb0370","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/glia.22861","article-title":"A2a and a2b adenosine receptors affect HIF-1alpha signaling in activated primary microglial cells","volume":"63","author":"Merighi","year":"2015","journal-title":"Glia"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0375","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2015.11.007","article-title":"Purinergic signalling in brain ischemia","volume":"104","author":"Pedata","year":"2016","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/bs.pmbts.2022.06.004_bb0380","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.pain.2014.09.016","article-title":"A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways","volume":"155","author":"Janes","year":"2016","journal-title":"Pain"},{"issue":"22","key":"10.1016\/bs.pmbts.2022.06.004_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228710","article-title":"Targeting adenosine receptors: a potential pharmacological avenue for acute and chronic pain","volume":"21","author":"Vincenzi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.004_bb0390","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/cdd.2009.131","article-title":"Adenosine signaling and function in glial cells","volume":"17","author":"Boison","year":"2010","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.004_bb0395","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0301-0082(93)90006-E","article-title":"Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn","volume":"41","author":"Salter","year":"1993","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0400","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.pain.2004.11.020","article-title":"Increased nociceptive response in mice lacking the adenosine A1 receptor","volume":"113","author":"Wu","year":"2005","journal-title":"Pain"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0405","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neuroscience.2014.10.065","article-title":"Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy","volume":"285","author":"Katz","year":"2015","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/bs.pmbts.2022.06.004_bb0410","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4097\/kja.19481","article-title":"Antiallodynic and anti-inflammatory effects of intrathecal R-PIA in a rat model of vincristine-induced peripheral neuropathy","volume":"73","author":"Kim","year":"2020","journal-title":"Korean J Anesthesiol"},{"issue":"2","key":"10.1016\/bs.pmbts.2022.06.004_bb0415","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.pain.2010.08.014","article-title":"Direct blockade of inflammatory hypernociception by peripheral A1 adenosine receptors: involvement of the NO\/cGMP\/PKG\/KATP signaling pathway","volume":"151","author":"Lima","year":"2010","journal-title":"Pain"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0420","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","article-title":"Chemokines, neuronal-glial interactions, and central processing of neuropathic pain","volume":"126","author":"Gao","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0425","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/glia.22592","article-title":"The A1 adenosine receptor as a new player in microglia physiology","volume":"62","author":"Luongo","year":"2014","journal-title":"Glia"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0430","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0304-3940(02)00524-4","article-title":"Effects of A(1) and A(2A) adenosine receptor ligands in mouse acute models of pain","volume":"328","author":"Bastia","year":"2002","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/bs.pmbts.2022.06.004_bb0435","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pain.2006.10.014","article-title":"Reduced response to the formalin test and lowered spinal NMDA glutamate receptor binding in adenosine A2A receptor knockout mice","volume":"129","author":"Hussey","year":"2007","journal-title":"Pain"},{"issue":"44","key":"10.1016\/bs.pmbts.2022.06.004_bb0440","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1523\/JNEUROSCI.3447-09.2009","article-title":"Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain","volume":"29","author":"Loram","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0445","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbi.2013.06.004","article-title":"Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A\/PKC signaling","volume":"33","author":"Loram","year":"2013","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/bs.pmbts.2022.06.004_bb0450","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-2999(88)90143-4","article-title":"Role of G-proteins and adenylate cyclase in antinociception produced by intrathecal purines","volume":"156","author":"Sawynok","year":"1988","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.1016\/bs.pmbts.2022.06.004_bb0455","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1007\/s00221-018-5377-1","article-title":"A3 adenosine receptor agonist attenuates neuropathic pain by suppressing activation of microglia and convergence of nociceptive inputs in the spinal dorsal horn","volume":"236","author":"Terayama","year":"2018","journal-title":"Exp Brain Res"},{"issue":"8","key":"10.1016\/bs.pmbts.2022.06.004_bb0460","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/bph.13446","article-title":"Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics","volume":"173","author":"Janes","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/bs.pmbts.2022.06.004_bb0465","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbi.2014.08.010","article-title":"Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy","volume":"44","author":"Janes","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"7","key":"10.1016\/bs.pmbts.2022.06.004_bb0470","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139299","article-title":"Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10","volume":"131","author":"Durante","year":"2021","journal-title":"J Clin Invest"},{"issue":"15","key":"10.1016\/bs.pmbts.2022.06.004_bb0475","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1523\/JNEUROSCI.4495-14.2015","article-title":"Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain","volume":"35","author":"Ford","year":"2015","journal-title":"J Neurosci"}],"container-title":["Progress in Molecular Biology and Translational Science","G Protein-Coupled Receptors - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117322000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117322000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:03:02Z","timestamp":1762560182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117322000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323994316"],"references-count":94,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2022.06.004","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}